TELLA, INC.
4Patents
3Active
4Granted
36Portfolio score
Filing activity: Dec 22, 2004 → Jan 22, 2016
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9404083B2 | Method for amplifying NK cells | Chemistry; Metallurgy | 4 | Active |
| US10172925B2 | Uses of partial peptides of survivin and variations thereof | Chemistry; Metallurgy | 3 | Active |
| US9205111B2 | Process for producing engineered targeted T cell and medicine | Chemistry; Metallurgy | 3 | Expired |
| US10253075B2 | WT1 antigenic polypeptide, and anti-tumor agent containing said polypeptide | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.